Page 20 - ARNM-1-1
P. 20

Advances in Radiotherapy
            & Nuclear Medicine                                                Seed implantation head-and-neck carcinoma



            9.2. Better precision and accuracy                 assistance for operators only requires a 6-month training

            All RSI-BT procedures are precise and accurate. First, the   program for experienced doctors, including interventional
            3D-PNCT can be matched very well to both the patient   radiologists, surgeons, and radiation oncologists.
            and tumor, and no positional errors can occur due to   10. Perspectives
            organ stabilization and no patient movement in the
            head-and-neck region due to immobilization. Second, all   RSI-BT has mainly been utilized in treating early-stage
            needle insertion follows the guide holes (ports) on the   prostate  carcinoma  with  ultrasound  guidance in  Western
            template according to the pre-planned designed template   Countries. 3D-PT-assisted CT-guided I-125 RSI-BT greatly
            base on CT images obtained preoperatively. It should be   expands the indications and enriches the aspects of BT.
            recognized that all the needles’ position adheres to the   Precision and ablative radiation for cancer treatment in
            pre-plan, assuring a successful, accurate, and high-quality   the future of anti-cancer treatment as conventional surgery
            I-125 RSI-BT under CT supervision. If the deviation in a   or EBRT show greater toxicity and long-term treatments
            needle’s position is observed to be more than 2 mm, a fine   and recovery time to normal life. For developing countries,
            adjustment can be made intraprocedurally until the real-  cancer treatment-related organ side effects and disruption
            time plan is exactly confirmed with the pre-plan algorithm.   in function makes the cost unreasonable. I-125 RSI-BT
            The toxicity incidence has been observed to have decreased   is minimally invasive and, most of the time is performed
            due to no OARs in the needle’s pathway.            under local anesthesia requiring the patient to spend only
                                                               1 day to recover to normal life. More and more prospective,
            9.3. Ablative doses                                large-scale randomized clinical trials should be performed
            I-125 RSI-BT can deliver very high radiation doses to   to evaluate and encourage the development of I-125 RSI-BT
            identified targets with 3D-PT-assisted CT guidance. With   for appropriate patients. In medical practice, the ultimate
            real-time adaptive dose optimization, RSI radiation doses   guideline of a therapeutic strategy is based on prospective
                                                                                         [49]
            of EQD2 should be more than 120 Gy compared with EBRT,   and randomized controlled trials . The I-125 RSI-BT has
            and tumor ablation with these higher doses of radiation is   produced long-lasting remission and extended patients’
            similar to interventional radiofrequency; however, organ   survival for many years. Precision ablation with BT has been
            function is preserved. EBRT has to penetrate the normal   confirmed in hundreds of thousands of patients in China
            tissues to reach the targets making the dose-escalation   for the past 20 years, which has promoted RSI-BT from an
            very difficult to achieve due to the normal tissues’ dose   experimental therapy to a routine clinical application. I-125
            limitation, and this is why EBRT is just an adjuvant   RSI-BT has been increasingly used in various sites for primary
            treatment and not a curative modality most of the time.  treatment. With the development of multimodality image
                                                               fusion, artificial intelligence TPS, robot assistant implantation
            9.4. Single operation                              systems, and stranded seeds, it is a great opportunity for the
            The I-125 RSI-BT is performed just once with an    I-125 RSI-BT to become soon an independent, minimally
            operative time of about 45 min to 1.5 h, usually averaging   invasive ablative discipline for cancer treatment or an
            about 1 h. This technique is an advanced version of the   adjuvant option with surgery or EBRT.
            hypofunctional, ablative RT. It should be referred to
            as stereotactic body radiotherapy (SABT). SBRT often   Acknowledgments
            requires 3 – 5 fractionated radiation treatments and 1 week   None.
            time. Fractionation with high-dose radiation is usually
            very few, so RSI-BT is the true ablative RT.       Funding

            9.5. Cost-effect benefit                           Special  fund  of  the  National  Clinical  Key  Specialty
                                                               Construction Program, P. R. China (2021).
            The last and greatest advantage of I-125 RSI-BT is its cost-
            effectiveness, which is relatively reasonable and more   Conflict of interest
            suitable for developing countries. All the investments
            required for I-125 RSI-BT are not as high as EBRT,   The authors declare that they have no conflicts of interest.
            not requiring significant space, construction, radiation   Author contributions
            protection, and machines. CT machines are accessible all
            around the world at present, and installation of support   Conceptualization: Gordon L. Grado, Junjie Wang
            devices such as the stabilization systems and BT-TPS are   Writing – original draft: Suqing Tian, Bin Qiu
            easy to obtain and utilize. The practice of I-125 RSI-BT has   Writing – review & editing: Ping Jiang, Yuliang Jiang,
            become relatively simple and convenient because 3D-PT   Zhe Ji, Mingwei Huang


            Volume 1 Issue 1 (2023)                         12                      https://doi.org/10.36922/arnm.0907
   15   16   17   18   19   20   21   22   23   24   25